TWA
EVFM

TCI Wealth Advisors’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

TCI Wealth Advisors’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18
Closed -$1K – 1731
2019
Q3 		$1K Buy
+18
New +$1.38K ﹤0.01% 1441

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LFS
Link Fund Solutions London, United Kingdom $157M AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCI Wealth Advisors's EVFM Position: Q4 2019 in Review

TCI Wealth Advisors sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2019, closing a stake of 18 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in EVFM in Q3 2019 and held it in 1 quarter. The position peaked at $1K in Q3 2019. 42 funds tracked by Wall St. Rank hold EVFM as of Q4 2019.

  • TCI Wealth Advisors reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • TCI Wealth Advisors sold 18 Evofem Biosciences, Inc. Common Stock shares in Q4 2019, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • TCI Wealth Advisors's Evofem Biosciences, Inc. Common Stock position peaked at $1K in Q3 2019.
  • 42 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2019.

Based on TCI Wealth Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.